← Back to All US Stocks

Orasure Technologies Inc. (OSUR) Stock Fundamental Analysis & AI Rating 2026

OSUR Nasdaq Surgical & Medical Instruments & Apparatus DE CIK: 0001116463
Recently Updated • Analysis: Apr 13, 2026 • SEC Data: 2025-12-31
STRONG SELL
90% Conf
Pending
Analysis scheduled

📊 OSUR Key Takeaways

Revenue: $115.0M
Net Margin: -59.8%
Free Cash Flow: $-53.2M
Current Ratio: 6.58x
Debt/Equity: 0.00x
EPS: $-0.94
AI Rating: STRONG SELL with 90% confidence
Orasure Technologies Inc. (OSUR) receives a STRONG SELL rating with 90% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $115.0M, net profit margin of -59.8%, and return on equity (ROE) of -20.2%, Orasure Technologies Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete OSUR stock analysis for 2026.

Is Orasure Technologies Inc. (OSUR) a Good Investment?

Claude

OraSure Technologies faces a structural business crisis characterized by a 38.1% revenue collapse, negative $49M operating cash flow, and sustained unprofitability with net income declining 252.5% YoY. While the balance sheet provides a ~4-year cash runway ($199.3M with $49-53M annual burn), the core business is not generating value, and there is no evidence of operational turnaround in the available data.

Why Buy Orasure Technologies Inc. Stock? OSUR Key Strengths

Claude
  • + Substantial cash reserves of $199.3M provide financial runway
  • + Excellent liquidity metrics (6.58x current ratio) enable near-term obligations
  • + Conservative capital structure with zero debt provides flexibility

OSUR Stock Risks: Orasure Technologies Inc. Investment Risks

Claude
  • ! Revenue collapse of 38.1% YoY indicates severe demand/market deterioration
  • ! Negative operating cash flow of -$49M demonstrates broken business model fundamentals
  • ! Negative free cash flow of -$53.2M is unsustainable; company survives on asset depletion not operations
  • ! Widening operating losses (-$72M) and negative ROE/ROA (-20.2%/-17.0%) indicate value destruction

Key Metrics to Watch

Claude
  • * Revenue stabilization and return to growth
  • * Operating cash flow return to positive territory
  • * Operating margin recovery toward breakeven
  • * Cash burn rate and remaining runway duration

Orasure Technologies Inc. (OSUR) Financial Metrics & Key Ratios

Revenue
$115.0M
Net Income
$-68.7M
EPS (Diluted)
$-0.94
Free Cash Flow
$-53.2M
Total Assets
$403.2M
Cash Position
$199.3M

💡 AI Analyst Insight

Strong liquidity with a 6.58x current ratio provides a solid financial cushion.

OSUR Profit Margin, ROE & Profitability Analysis

Gross Margin 41.9%
Operating Margin -62.6%
Net Margin -59.8%
ROE -20.2%
ROA -17.0%
FCF Margin -46.3%

OSUR vs Healthcare Sector: How Orasure Technologies Inc. Compares

How Orasure Technologies Inc. compares to Healthcare sector averages

Net Margin
OSUR -59.8%
vs
Sector Avg 12.0%
OSUR Sector
ROE
OSUR -20.2%
vs
Sector Avg 15.0%
OSUR Sector
Current Ratio
OSUR 6.6x
vs
Sector Avg 2.0x
OSUR Sector
Debt/Equity
OSUR 0.0x
vs
Sector Avg 0.6x
OSUR Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Orasure Technologies Inc. Stock Overvalued? OSUR Valuation Analysis 2026

Based on fundamental analysis, Orasure Technologies Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-20.2%
Sector avg: 15%
Net Profit Margin
-59.8%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Orasure Technologies Inc. Balance Sheet: OSUR Debt, Cash & Liquidity

Current Ratio
6.58x
Quick Ratio
5.80x
Debt/Equity
0.00x
Debt/Assets
15.5%
Interest Coverage
-418.42x
Long-term Debt
N/A

OSUR Revenue & Earnings Growth: 5-Year Financial Trend

OSUR 5-year financial data: Year 2021: Revenue $233.7M, Net Income $16.7M, EPS $0.27. Year 2022: Revenue $387.5M, Net Income -$14.9M, EPS $0.22. Year 2023: Revenue $405.5M, Net Income -$23.0M, EPS $-0.32. Year 2024: Revenue $405.5M, Net Income -$17.1M, EPS $-0.24. Year 2025: Revenue $405.5M, Net Income $53.7M, EPS $0.72.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Orasure Technologies Inc.'s revenue has grown significantly by 74% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.72 reflects profitable operations.

OSUR Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-46.3%
Free cash flow / Revenue

OSUR Quarterly Earnings & Performance

Quarterly financial performance data for Orasure Technologies Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $27.1M -$615.0K $-0.06
Q2 2025 $31.2M -$615.0K $-0.01
Q1 2025 $29.9M -$3.6M $-0.05
Q3 2024 $39.9M -$615.0K $-0.06
Q2 2024 $54.3M -$615.0K $-0.01
Q1 2024 $54.1M -$3.6M $-0.05
Q3 2023 $89.2M -$4.8M $0.08
Q2 2023 $80.2M -$4.8M $-0.07

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Orasure Technologies Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$49.0M
Cash generated from operations
Stock Buybacks
$15.0M
Shares repurchased (TTM)
Capital Expenditures
$4.2M
Investment in assets
Dividends
None
No dividend program

OSUR SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Orasure Technologies Inc. (CIK: 0001116463)

📋 Recent SEC Filings

Date Form Document Action
Mar 30, 2026 4 xslF345X06/wk-form4_1774906409.xml View →
Mar 30, 2026 8-K d138279d8k.htm View →
Mar 23, 2026 4 xslF345X06/form4.xml View →
Mar 23, 2026 4 xslF345X06/form4.xml View →
Mar 19, 2026 4 xslF345X06/form4.xml View →

Frequently Asked Questions about OSUR

What is the AI rating for OSUR?

Orasure Technologies Inc. (OSUR) has an AI rating of STRONG SELL with 90% confidence, based on fundamental analysis of SEC EDGAR filings.

What are OSUR's key strengths?

Claude: Substantial cash reserves of $199.3M provide financial runway. Excellent liquidity metrics (6.58x current ratio) enable near-term obligations.

What are the risks of investing in OSUR?

Claude: Revenue collapse of 38.1% YoY indicates severe demand/market deterioration. Negative operating cash flow of -$49M demonstrates broken business model fundamentals.

What is OSUR's revenue and growth?

Orasure Technologies Inc. reported revenue of $115.0M.

Does OSUR pay dividends?

Orasure Technologies Inc. does not currently pay dividends.

Where can I find OSUR SEC filings?

Official SEC filings for Orasure Technologies Inc. (CIK: 0001116463) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is OSUR's EPS?

Orasure Technologies Inc. has a diluted EPS of $-0.94.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is OSUR a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Orasure Technologies Inc. has a STRONG SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is OSUR stock overvalued or undervalued?

Valuation metrics for OSUR: ROE of -20.2% (sector avg: 15%), net margin of -59.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy OSUR stock in 2026?

Our dual AI analysis gives Orasure Technologies Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is OSUR's free cash flow?

Orasure Technologies Inc.'s operating cash flow is $-49.0M, with capital expenditures of $4.2M. FCF margin is -46.3%.

How does OSUR compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -59.8% (avg: 12%), ROE -20.2% (avg: 15%), current ratio 6.58 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 13, 2026 | Data as of: 2025-12-31 | Powered by Claude AI